- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Scancell Hldgs Plc (SCLP)
London
Currency in GBP
Disclaimer
13.50
+0.20(+1.50%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.30
14.00
52 wk Range
8.60
19.75
SCLP Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
Scancell Hldgs Plc stock price live, this page displays LON SCLP stock exchange data. View the SCLP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Scancell Hldgs Plc real time stock price chart below.
What Is the Scancell Hldgs Plc Stock Price Today?
The Scancell Hldgs Plc stock price today is 13.50.
What Is the Stock Symbol for Scancell Hldgs Plc?
The stock symbol for Scancell Hldgs Plc is "SCLP."
What Stock Exchange Does Scancell Hldgs Plc Trade On?
Scancell Hldgs Plc is listed and trades on the London stock exchange.
Is Scancell Hldgs Plc a Good Stock to Buy?
Determining whether Scancell Hldgs Plc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SCLP quote. (ISIN: GB00B63D3314)
What Is the Scancell Hldgs Plc Stock Price Today?
The Scancell Hldgs Plc stock price today is 13.50.
What Is the Stock Symbol for Scancell Hldgs Plc?
The stock symbol for Scancell Hldgs Plc is "SCLP."
What Stock Exchange Does Scancell Hldgs Plc Trade On?
Scancell Hldgs Plc is listed and trades on the London stock exchange.
Is Scancell Hldgs Plc a Good Stock to Buy?
Determining whether Scancell Hldgs Plc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SCLP quote. (ISIN: GB00B63D3314)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.3014.00
52 wk Range
8.6019.75
UnlockSCLP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
24.77
Upside
+83.48%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Scancell Hldgs Plc Company Profile
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer. It also develops Modi-1, a citrullinated peptides vaccine that is in phase I/II clinical trials for the treatment of solid tumors including triple negative breast, ovarian, renal, and head and neck cancers; and Modi-2, which targets homocitrullinated cancer antigens. In addition, the company focuses to develop SCOV1 and SCOV2 COVIDITY, a DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.
Compare SCLP to Peers and Sector
Metrics to compare | SCLP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSCLPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −21.2x | −3.5x | −0.6x | |
PEG Ratio | −4.57 | −0.04 | 0.00 | |
Price/Book | −35.4x | 1.9x | 2.6x | |
Price / LTM Sales | - | 23.3x | 3.2x | |
Upside (Analyst Target) | 72.6% | 99.2% | 47.4% | |
Fair Value Upside | Unlock | 25.3% | 6.2% | Unlock |
FAQ
What Is the Scancell (SCLP) Stock Price Today?
The Scancell stock price today is 13.50.
What Stock Exchange Does Scancell Trade On?
Scancell is listed and trades on the London stock exchange.
What Is the Stock Symbol for Scancell?
The stock symbol for Scancell is "SCLP."
What Is the Scancell Market Cap?
As of today, Scancell market cap is 123.92M.
What is Scancell Earnings Per Share?
The Scancell EPS is -0.007.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.